CareDx Inc reports results for the quarter ended in January - Earnings Summary

CareDx

01/08/2024 02:09

* CareDx Inc  CDNA.OQ  reported quarterly adjusted earnings
of 25
cents​​ per share for the quarter ended in January, higher than
the same quarter last year, when the company reported EPS of -18
cents.  The mean expectation of eight analysts for the quarter
was for a loss of 14 cents per share. Wall Street expected
results to range from -21 cents to -12 cents per share.
    * Revenue rose 31.3% to $92.27 million from a year ago;
analysts
expected $67.86 million. 
    * CareDx Inc's reported EPS for the quarter was a loss of 3
cents​.
    * The company reported a quarterly loss of $1.39 million.
    * CareDx Inc shares had risen by 20.8% this quarter and
gained 56.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 4% in
the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for CareDx Inc is
$17.00 
This summary was machine generated from LSEG data August 1 at
01:09 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.14          0.25           Beat
 Mar. 31 2024      -0.21          -0.03          Beat
 Dec. 31 2023      -0.27          -0.17          Beat
 Sep. 30 2023      -0.40          -0.18          Beat